HPV Vaccine Information for Clinicians – Fact Sheet
to gain a comprehensive understanding of hpv vaccine misinformation narratives on social media. while health misinformation is contained within initial creator posts, the spread of false information can often be compounded by majority one-sided dialogue found in the comment sections. [ 9 ] thus, ...
Cervical cancer is currently prevented by Pap smears and/or HPV testing and ablation of high-grade squamous intraepithelial lesions (HSILs). However, the US Food and Drug Administration approved a preventive HPV vaccine on 8 June 2006 for the immunization of women between 9–26 years of age. ...
17.Schiller JT,Castellsagué X,Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F123-38.18.Zhu F, Li J, Hu Y, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chine...
issued an executive order requiring that girls entering 6th grade be vaccinated with the HPV vaccine, the public health community was thrilled. That would have made Texas the first state to mandate the vaccination. The excitement, however, was short-lived. The Texas legislature overrode the execut...
Human papillomavirus (HPV) is the most common sexually transmitted infection and is associated with many types of cancers that disproportionately impact Hispanics. An HPV vaccine is available for individuals ages 9—45 that can prevent up to 90% of HPV-a
In this study, 83.6% of students who had exposure to the information knew HPV infection has a vaccine, 80.5% of them knew HPV infection can cause cervical cancer, 89.8% of students want to get HPV vaccine and 62.9% of them knew one can get HPV infection through se...
The HPV4 vaccine is beneficial for at least 5 years, and studies are being done to determine overall long-term efficacy. Because the HPV4 vaccine is protective against 4 HPV types, it is important for women to be vaccinated even if they know they were previously infected with 1 or more ...
In Morocco, the vaccine in theory could prevent 86.5% of cervical cancer cases. Despite the development of vaccination, screening programs remain a mainstay in the secondary prevention of cervical cancer. Identifying the factors, other than HPV, that contribute to the development of cervical cancer...
17.Schiller JT,Castellsagué X,Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F123-38. 18.Zhu F, Li J, Hu Y, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese gi...